AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Rivaroxaban in Nigeria
12 products registered with NAFDAC — 12 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Xarelto 2.5 mg Tablet** Tablet | C4-1332 | Bayer Nigeria Limited | active | 27 Apr 2031 |
| Xarelto 20 mg Tablet** Tablet | B4-4878 | Bayer Nigeria Limited | active | 27 Apr 2031 |
| Ixobran 20 Tablets Tablet | A4-101169 | Mega Lifesciences Nigeria Limited | active | 29 Jan 2030 |
| Ixobran 10 Tablets Tablet | A4-101167 | Mega Lifesciences Nigeria Limited | active | 29 Jan 2030 |
| Ixorban 15 Tablets Tablet | A4-101168 | Mega Lifesciences Nigeria Limited | active | 29 Jan 2030 |
| Rivaroxaban 20 mg Tablet | A4-101100 | Swiss Pharma Nigeria Limited | active | 21 Nov 2029 |
| Rivaroxaban 15 mg Tablet | A4-101099 | Swiss Pharma Nigeria Limited | active | 21 Nov 2029 |
| Rivaroxaban 10 mg Tablet | A4-101098 | Swiss Pharma Nigeria Limited | active | 21 Nov 2029 |
| Xarelto 10 mg Tablet** Tablet | A4-6191 | Bayer Nigeria Limited | active | 26 Jun 2029 |
| Varoxa 20 Tablets Tablet | A4-100766 | Micro Nova Pharmaceuticals Ind Ltd | active | 27 Feb 2029 |
| Varoxa 10 Tablets (wrong smpc) Tablet | A4-100765 | Micro Nova Pharmaceuticals Ind Ltd | active | 27 Feb 2029 |
| Xarelto 15 mg Tablet** Tablet | B4-2093 | Bayer Nigeria Limited | active | 29 Nov 2025 |
Rivaroxaban — NAFDAC Registration Details
NAFDAC (Nigeria) has 12 registered products containing Rivaroxaban, of which 12 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Rivaroxaban registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.